Abstract
To present an innovative approach based on the methods of Artificial Intelligence to better predict N status in low risk prostate cancer pts, integrating some important clinical and herapeutic parameters (Gleason Score/sum, age, initial PSA, neoadjuvant or neoadjuvant/concomitant hormonal therapy vs no hormonal therapy), known before radiotherapy (RT).
Information
Library
Documents
Statistics
Downloads
Downloads per month over past year